Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
18h
Medpage Today on MSNSemaglutide Tied to Small Risk of Potentially Blinding Eye ConditionThe use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
The labels for diabetes therapies Ozempic and Trulicity don’t include that ... they failed to warn of severe gastrointestinal side effects that can be caused by Ozempic and Mounjaro (tirzepatide ...
promotion of islet β cell proliferation and have minimal side effects. When asked about what other innovations Novo Nordisk is aiming to achieve in diabetes control, a spokesperson for the ...
Clopidogrel is a prescription drug used to reduce the risk of heart attack and stroke. Learn about the common, mild, and ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
However, recent studies have highlighted potential adverse effects, such as anxiety and depression, underscoring the importance of practicing mindfulness safely and being aware of its potential risks.
Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.
Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid into the brain that potentially contributes to neurological symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results